INS and metabolic dysfunction-associated steatotic liver disease: The LBW individuals with NAFLD were characterized by elevated hepatic insulin resistance, fasting levels of insulin, C-peptide, and triglycerides (TG), as well as elevated plasma levels of leptin and GLP-1, compared with both LBW and normal-birth-weight (NBW) individuals without NAFLD [3].